TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE ASIA PACIFIC SMART CONTACT LENS MARKET 14
1.4 LIMITATIONS 16
1.5 MARKETS COVERED 16
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 DESIGN LIFELINE CURVE 23
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.9 DBMR MARKET POSITION GRID 25
2.10 MARKET APPLICATION COVERAGE GRID 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 31
4.1 PORTERS FIVE FORCES 32
4.2 PESTEL ANALYSIS 33
4.3 LIST OF TERMINATED/PAUSED PIPELINE PROJECTS 34
4.4 PATENT ANALYSIS 35
4.5 PIPELINE ANALYSIS FOR THE ASIA PACIFIC SMART CONTACT LENS MARKET 37
4.6 INDUSTRY INSIGHT 38
5 ASIA PACIFIC SMART CONTACT LENS MARKET: REGULATIONS 39
6 MARKET OVERVIEW 42
6.1 DRIVERS 44
6.1.1 INCREASE IN PREVALENCE OF REFRACTIVE ERROR 44
6.1.2 RISING CASES OF DIABETIC RETINOPATHY 45
6.1.3 INCREASING R&D ACTIVITIES BY KEY MARKET PLAYERS FOR SMART CONTACT LENS 45
6.1.4 RISE IN THE PREVALENCE OF EYE DISORDER 46
6.2 RESTRAINTS 46
6.2.1 INCREASING SIDE EFFECTS ASSOCIATED WITH CONTACT LENSES 46
6.2.2 GROWING ACCEPTANCE OF REFRACTIVE SURGERIES 47
6.3 OPPORTUNITIES 47
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN CONTACT LENSES 47
6.3.2 INCREASING PREFERENCE FOR CONTACT LENSES INSTEAD OF EYEGLASSES 48
6.4 CHALLENGES 48
6.4.1 SAFETY CONCERNS ASSOCIATED WITH THE USE OF CONTACT LENSES 48
6.4.2 STRICT REGULATIONS AND STANDARDS FOR APPROVAL OF CONTACT LENSES 49
7 ASIA PACIFIC SMART CONTACT LENS MARKET, BY DESIGN 50
7.1 OVERVIEW 51
7.2 MICRO LED DISPLAY CONTACT LENS 54
7.3 DIAGNOSTIC SENSOR INTEGRATED CONTACT LENS 54
7.4 PHOTODETECTOR CONTACT LENSES 55
7.5 DRUG ELUDING CONTACT LENSES 55
7.6 ELECTROCHEMICAL CONTACT LENS SENSORS 56
7.7 LIGHT DIFFRACTIVE CONTACT LENSES 56
7.8 FLUORESCENCE-BASED CONTACT LENSES 57
7.9 OTHERS 57
8 ASIA PACIFIC SMART CONTACT LENS MARKET, BY MATERIAL 58
8.1 OVERVIEW 59
8.2 POLY (2-HYDROXYETHYL METHACRYLATE) (PHEMA) 62
8.3 POLYVINYL ALCOHOL (PVA) 62
8.4 POLYACRYLAMIDE (PA) 63
8.5 POLYETHYLENE TEREPHTHALATE (PET) 63
8.6 POLYDIMETHYLSILOXANE (PDMS) 64
8.7 OTHER 65
9 ASIA PACIFIC SMART CONTACT LENS MARKET, BY APPLICATION 66
9.1 OVERVIEW 67
9.2 MONITORING 70
9.2.1 EYE PRESSURE MONITORING 70
9.2.2 GLUCOSE LEVELS MONITORING 70
9.3 THERAPEUTICS 71
9.3.1 ALLERGY RELIEF 71
9.3.2 CORNEAL INJURY 72
9.3.3 EYE INJURIES 72
9.3.4 OTHER 72
9.4 OTHER APPLICATION 72
9.4.1 FARSIGHTEDNESS 73
9.4.2 AUGMENTED REALITY (AR/VR) 73
9.4.3 NIGHT VISION 73
9.4.4 OTHERS 73
10 ASIA PACIFIC SMART CONTACT LENS MARKET, BY USABILITY 74
10.1 OVERVIEW 75
10.2 SINGLE USE 78
10.3 EXTENDED USE 79
11 ASIA PACIFIC SMART CONTACT LENS MARKET, BY TECHNOLOGY 80
11.1 OVERVIEW 81
11.2 FLUORESCENCE-BASED SENSING TECHNOLOGY 84
11.3 HOLOGRAPHIC SENSING TECHNOLOGY 85
11.4 COLORIMETRIC BASED SENSING TECHNOLOGY 86
11.5 ELECTROCHEMICAL-BASED TECHNOLOGIES 87
11.6 OTHER 88
12 ASIA PACIFIC SMART CONTACT LENS MARKET, BY POPULATION 89
12.1 OVERVIEW 90
12.2 GERIATRIC 93
12.3 ADULT 94
12.4 PEDIATRIC 95
13 ASIA PACIFIC SMART CONTACT LENS MARKET, BY END USER 96
13.1 OVERVIEW 97
13.2 EYE HOSPITAL 100
13.3 OPHTHALMOLOGY CLINICS 101
13.4 HOMECARE SETTING 102
13.5 OTHERS 103
14 ASIA PACIFIC SMART CONTACT LENS MARKET, BY DISTRIBUTION CHANNEL 104
14.1 OVERVIEW 105
14.2 RETAIL STORES 108
14.2.1 PHARMACIES 108
14.2.2 INDEPENDENT BRAND SHOWROOMS 109
14.2.3 OTHERS 109
14.3 ONLINE STORES 109
14.3.1 E-COMMERCE WEBSITES 110
14.3.2 COMPANY-OWNED WEBSITES 110
14.4 EYE CARE PRACTITIONERS 110
14.5 OTHERS 111
15 ASIA PACIFIC SMART CONTACT LENS MARKET, BY REGION 112
15.1 ASIA-PACIFIC 113
15.1.1 JAPAN 122
16 SWOT ANALYSIS 126
17 COMPANY PROFILE 127
17.1 SENSIMED AG 127
17.1.1 COMPANY SNAPSHOT 127
17.1.2 PRODUCT PORTFOLIO 127
17.1.3 RECENT DEVELOPMENT 127
17.2 AZALEA VISION 128
17.2.1 COMPANY SNAPSHOT 128
17.2.2 PRODUCT PORTFOLIO 128
17.2.3 RECENT DEVELOPMENTS 128
17.3 E-VISION SMART OPTICS, INC. 129
17.3.1 COMPANY SNAPSHOT 129
17.3.2 PRODUCT PORTFOLIO 129
17.3.3 RECENT DEVELOPMENT 129
17.4 GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJI SAN. VE TIC. A.. 130
17.4.1 COMPANY SNAPSHOT 130
17.4.2 PIPELINE PORTFOLIO 130
17.4.3 RECENT DEVELOPMENTS 130
17.5 INNOVEGA INC. 131
17.5.1 COMPANY SNAPSHOT 131
17.5.2 PIPELINE PORTFOLIO 131
17.5.3 RECENT DEVELOPMENTS 131
17.6 INWITH CORP 132
17.6.1 COMPANY SNAPSHOT 132
17.6.2 PIPELINE PORTFOLIO 132
17.6.3 RECENT DEVELOPMENT 132
17.7 MEDIPRINT 133
17.7.1 COMPANY SNAPSHOT 133
17.7.2 PRODUCT PORTFOLIO 133
17.7.3 RECENT DEVELOPMENTS 133
17.8 RAAYONNOVA 134
17.8.1 COMPANY SNAPSHOT 134
17.8.2 PRODUCT PORTFOLIO 134
17.8.3 RECENT DEVELOPMENTS 134
17.9 SAMSUNG 135
17.9.1 COMPANY SNAPSHOT 135
17.9.2 REVENUE ANALYSIS 135
17.9.3 PRODUCT PORTFOLIO 136
17.9.4 RECENT DEVELOPMENT 136
18 QUESTIONNAIRE 137
19 RELATED REPORTS 141

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.